| Literature DB >> 27411304 |
Hongbing Jia1, Pengcheng Du2,3, Hui Yang1, Yuanyuan Zhang2,3, Jing Wang1, Wen Zhang3,4, Guiling Han1, Na Han3,4, Zhiyuan Yao1, Haiyin Wang3,4, Jing Zhang1, Zhen Wang3,4, Qingming Ding1, Yujun Qiang3,4, Frédéric Barbut5, George F Gao6, Yongtong Cao7, Ying Cheng8, Chen Chen9,10.
Abstract
BACKGROUND: The rapid spread of Clostridium difficile NAP1/BI/027 (C. difficile 027) has become one of the leading threats of healthcare-associated infections worldwide. However, C. difficile 027 infections have been rarely reported in Asia, particularly in China.Entities:
Keywords: Clostridium difficile; NAP1/BI/027; Nosocomial infection; Outbreak; Whole genome sequencing
Mesh:
Year: 2016 PMID: 27411304 PMCID: PMC4942892 DOI: 10.1186/s12864-016-2708-0
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Occurrence of CDI in this ward from March 2012 to May 2014. The x-axis represents the time line and the y-axis represents the patient ID. The green bars represent the period of hospital stay of each patient, the purple and yellow lines represent the dates of bouts of diarrhea and C. difficile isolation, respectively. The isolate 13B from blood is marked by a red star (the same in other figures). The number of new cases in each month is displayed using vertical bars at the top, red for NAP1/BI/027 cases, and gray for remaining cases
Description of the patients with C. difficile infection
| Characteristics | Value |
|---|---|
| No. of patients (%) | 20 (100) |
| Males | 14 (70.0) |
| Females | 6 (30.0) |
| Age range (mean) | 67–93 (80.9) |
| No. (%) of patients with nosocomial diarrhea | 18 (90.0) |
| Length of hospital stay [range, days (mean)] | 16–54 (28.6) |
| No. (%) of patients treated before diarrhea with the following | |
| Fluoroquinolones | 13 (65.0) |
| 4th generation cephalosporins | 8 (40.0) |
| 3rd generation cephalosporins | 7 (35.0) |
| Carbapenems | 5 (25.0) |
| Penicillins + β-lactamase inhibitor | 2 (10.0) |
| Glycopeptides | 1 (5.0) |
| Macrolides | 1 (5.0) |
| Cephamycins | 1 (5.0) |
Fig. 2Capillary gel electrophoresis fingerprint of ribotyping of all C. difficile strains isolated from CDI patients in this study. Each lane represents as following: lane M, DNA marker (15 ~ 1500 bp); lane UK1, reference strain UK1 (NAP1/BI/RT027); other lanes, the 22 isolates from 20 CDI patients
Fig. 3a Phylogenetic tree of 22 isolates from this study and two reference strains R20291 (ST1) and M68 (ST37) reconstructed by BEAST based on the multi-mapping results of REALPHY. The strain ID is coordinate to patient ID. b SNP pattern and relationship of NAP1/BI/027 isolates. Thirteen isolates from 11 cases (13A, 13B, and 13C were all from patient 13) are clustered using NAP1/BI/027 strain R20291 as the outgroup. The light blue squares represent mutations compared to R20291
Fig. 4The temporal and spatial transmission map with three potential risks for C. difficile NAP1/BI/027 spreading. The transmission connections in two consecutive years were marked using blue and red lines, respectively. The full lines represent the potential transfer route with both genomics and epidemic evidence, and dashed lines connected the patients among whom only have potential genetic links. ”?” represented the unknown nodes during the transmission and evolution. The architectural structure, room arrangement, and distribution of NAP1/BI/027 cases in this ward were displayed at the bottom. Patients during the two outbreaks are distinguished by different colors of background: red for those in 2012 and blue for those in 2013 to 2014